•Cystic Fibrosis-Associated Inflammatory Bowel Disease: a Case Series and Literature Review
•[Gly2]-GLP-2(1-5)：An Ultra-Short GLP-2 Peptide for Intestinal Mucosal Protection in Inflammatory Bowel Disease
•Entering a new age of innovation in IBD clinical trial design
•Supporting patients using a digital self-management intervention for symptoms of fatigue, pain, and urgency/incontinence in Inflammatory Bowel Disease: a mixed methods process evaluation of trial facilitators
•Multiple switches between infliximab originator and biosimilars in pediatric inflammatory bowel disease
